Use of Oral Vasopressin V<sub>2</sub> Receptor Antagonist for Hyponatremia in Acute Brain Injury
Sang‐Beom Jeon(Ulsan College), Kiwon Lee(Columbia University), H. Alex Choi(Texas Medical Center), Christine Lesch(NewYork–Presbyterian Hospital), Stephan A. Mayer(Westchester Medical Center), Myung Chun Kim(Neurology, Inc), Neeraj Badjatia(University of Maryland, Baltimore), Jan Claassen(Columbia University)
Cited by 11
Related Papers
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
|The Lancet|2020|2.3k
Guidelines for the Evaluation and Management of Status Epilepticus
|Neurocritical Care|2012|1.6k
A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC)
|Intensive Care Medicine|2019|623
Defining Vasospasm After Subarachnoid Hemorrhage
|Stroke|2009|592